Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-26-022630

Chief Executive Officer gave up 4,084 shares (to pay taxes)

  • Chief Executive Officer acquired 12,873 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Robinson Chandler · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-30 Exercise or conversion : show line 1 in the form +12,873 103,351 D
2026-06-30 Shares withheld for taxes : show line 2 in the form −4,084 $92.59 $378,138 99,267 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-30 Exercise or conversion : show line 3 in the form Restricted Stock Unit −12,873 93,403 D
Loading xslF345X06/rdgdoc.xml…